{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,7]],"date-time":"2025-11-07T13:26:37Z","timestamp":1762521997626,"version":"3.37.3"},"reference-count":59,"publisher":"Frontiers Media SA","funder":[{"DOI":"10.13039\/501100004281","name":"Narodowe Centrum Nauki","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100004281","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004569","name":"Ministerstwo Nauki i Szkolnictwa Wy\u017cszego","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100004569","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Cell. Neurosci."],"DOI":"10.3389\/fncel.2017.00082","type":"journal-article","created":{"date-parts":[[2017,3,27]],"date-time":"2017-03-27T23:43:32Z","timestamp":1490658212000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":13,"title":["Reduction of Huntington\u2019s Disease RNA Foci by CAG Repeat-Targeting Reagents"],"prefix":"10.3389","volume":"11","author":[{"given":"Martyna O.","family":"Urbanek","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Agnieszka","family":"Fiszer","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Wlodzimierz J.","family":"Krzyzosiak","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1965","published-online":{"date-parts":[[2017,3,28]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"1053","DOI":"10.1038\/mt.2009.17","article-title":"Nonallele-specific silencing of mutant and wild-type huntingtin demonstrates therapeutic efficacy in Huntington\u2019s disease mice.","volume":"17","author":"Boudreau","year":"2009","journal-title":"Mol. Ther."},{"key":"B2","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1111\/bpa.12387","article-title":"MAP2 splicing is altered in Huntington\u2019s disease.","volume":"27","author":"Cabrera","year":"2016","journal-title":"Brain Pathol."},{"key":"B3","doi-asserted-by":"publisher","first-page":"2178","DOI":"10.1038\/mt.2011.201","article-title":"Potent and selective antisense oligonucleotides targeting single-nucleotide polymorphisms in the Huntington disease gene \/ allele-specific silencing of mutant huntingtin.","volume":"19","author":"Carroll","year":"2011","journal-title":"Mol. Ther."},{"key":"B4","doi-asserted-by":"publisher","first-page":"9350","DOI":"10.1093\/nar\/gkv964","article-title":"A cytoplasmic pathway for gapmer antisense oligonucleotide-mediated gene silencing in mammalian cells.","volume":"43","author":"Castanotto","year":"2015","journal-title":"Nucleic Acids Res."},{"key":"B5","doi-asserted-by":"publisher","first-page":"3852","DOI":"10.1093\/nar\/gkq1323","article-title":"Mutant CAG repeats of Huntingtin transcript fold into hairpins, form nuclear foci and are targets for RNA interference.","volume":"39","author":"De Mezer","year":"2011","journal-title":"Nucleic Acids Res."},{"key":"B6","doi-asserted-by":"publisher","first-page":"17204","DOI":"10.1073\/pnas.0708285104","article-title":"Therapeutic silencing of mutant huntingtin with siRNA attenuates striatal and cortical neuropathology and behavioral deficits.","volume":"104","author":"DiFiglia","year":"2007","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"key":"B7","doi-asserted-by":"publisher","first-page":"1711","DOI":"10.1021\/cb300135h","article-title":"A small molecule that targets r(CGG) exp and improves defects in fragile X-associated tremor ataxia syndrome.","volume":"7","author":"Disney","year":"2012","journal-title":"ACS Chem. Biol."},{"key":"B8","doi-asserted-by":"publisher","first-page":"759","DOI":"10.18388\/abp.2016_1336","article-title":"Silencing of genes responsible for polyQ diseases using chemically modified single-stranded siRNAs.","volume":"63","author":"Fiszer","year":"2016","journal-title":"Acta Biochim. Pol."},{"key":"B9","doi-asserted-by":"publisher","first-page":"683","DOI":"10.1007\/s00109-013-1016-2","article-title":"RNA toxicity in polyglutamine disorders: concepts, models, and progress of research.","volume":"91","author":"Fiszer","year":"2013","journal-title":"J. Mol. Med."},{"key":"B10","doi-asserted-by":"publisher","first-page":"6787","DOI":"10.1093\/nar\/gku385","article-title":"Oligonucleotide-based strategies to combat polyglutamine diseases.","volume":"42","author":"Fiszer","year":"2014","journal-title":"Nucleic Acids Res."},{"key":"B11","doi-asserted-by":"publisher","first-page":"5578","DOI":"10.1093\/nar\/gkr156","article-title":"Inhibition of mutant huntingtin expression by RNA duplex targeting expanded CAG repeats.","volume":"39","author":"Fiszer","year":"2011","journal-title":"Nucleic Acids Res."},{"key":"B12","doi-asserted-by":"publisher","first-page":"10426","DOI":"10.1093\/nar\/gkt825","article-title":"Self-duplexing CUG repeats selectively inhibit mutant huntingtin expression.","volume":"41","author":"Fiszer","year":"2013","journal-title":"Nucleic Acids Res."},{"issue":"6","key":"B13","doi-asserted-by":"publisher","DOI":"10.1186\/1471-2199-13-6","article-title":"An evaluation of oligonucleotide-based therapeutic strategies for polyQ diseases.","volume":"13","author":"Fiszer","year":"2012","journal-title":"BMC Mol. Biol."},{"key":"B14","doi-asserted-by":"publisher","first-page":"85","DOI":"10.1038\/nsmb.1958","article-title":"Selective silencing of mutated mRNAs in DM1 by using modified hU7-snRNAs.","volume":"18","author":"Fran\u00e7ois","year":"2011","journal-title":"Nat. Struct. Mol. Biol."},{"key":"B15","doi-asserted-by":"publisher","first-page":"211","DOI":"10.1016\/j.celrep.2013.12.013","article-title":"RNAi factors are present and active in human cell nuclei.","volume":"6","author":"Gagnon","year":"2014","journal-title":"Cell Rep."},{"key":"B16","doi-asserted-by":"publisher","first-page":"1299","DOI":"10.1515\/hsz-2012-0218","article-title":"Triplet repeats in transcripts: structural insights into RNA toxicity.","volume":"393","author":"Galka-Marciniak","year":"2012","journal-title":"Biol. Chem."},{"key":"B17","doi-asserted-by":"publisher","first-page":"6591","DOI":"10.1093\/nar\/gku275","article-title":"Lomofungin and dilomofungin: inhibitors of MBNL1-CUG RNA binding with distinct cellular effects.","volume":"42","author":"Hoskins","year":"2014","journal-title":"Nucleic Acids Res."},{"key":"B18","doi-asserted-by":"publisher","first-page":"1183","DOI":"10.1016\/j.chembiol.2010.10.013","article-title":"Allele-selective inhibition of huntingtin expression by switching to an miRNA-like RNAi mechanism.","volume":"17","author":"Hu","year":"2010","journal-title":"Chem. Biol."},{"key":"B19","doi-asserted-by":"publisher","first-page":"478","DOI":"10.1038\/nbt.1539","article-title":"Allele-specific silencing of mutant huntingtin and ataxin-3 genes by targeting expanded CAG repeats in mRNAs.","volume":"27","author":"Hu","year":"2009","journal-title":"Nat. Biotechnol."},{"key":"B20","doi-asserted-by":"publisher","first-page":"9471","DOI":"10.1021\/jm400794z","article-title":"Developing bivalent ligands to target CUG triplet repeats, the causative agent of myotonic dystrophy type 1.","volume":"56","author":"Jahromi","year":"2013a","journal-title":"J. Med. Chem."},{"key":"B21","doi-asserted-by":"publisher","first-page":"1037","DOI":"10.1021\/cb400046u","article-title":"A novel CUGexp\u22c5MBNL1 inhibitor with therapeutic potential for myotonic dystrophy type 1.","volume":"8","author":"Jahromi","year":"2013b","journal-title":"ACS Chem. Biol."},{"key":"B22","doi-asserted-by":"publisher","first-page":"9050","DOI":"10.1093\/nar\/gkw803","article-title":"Identifying proteins that bind to specific RNAs - focus on simple repeat expansion diseases.","volume":"44","author":"Jazurek","year":"2016","journal-title":"Nucleic Acids Res."},{"key":"B23","doi-asserted-by":"publisher","first-page":"1085","DOI":"10.1261\/rna.056499.116","article-title":"Stable association of RNAi machinery is conserved between the cytoplasm and nucleus of human cells.","volume":"22","author":"Kalantari","year":"2016","journal-title":"RNA"},{"key":"B24","doi-asserted-by":"publisher","first-page":"R53","DOI":"10.1093\/hmg\/ddv442","article-title":"Gene suppression strategies for dominantly inherited neurodegenerative diseases: lessons from Huntington\u2019s disease and spinocerebellar ataxia.","volume":"25","author":"Keiser","year":"2016","journal-title":"Hum. Mol. Genet."},{"key":"B25","doi-asserted-by":"publisher","first-page":"1551","DOI":"10.1093\/hmg\/ddt542","article-title":"High-content screening identifies small molecules that remove nuclear foci, affect MBNL distribution and CELF1 protein levels via a PKC-independent pathway in myotonic dystrophy cell lines.","volume":"23","author":"Ketley","year":"2014","journal-title":"Hum. Mol. Genet."},{"key":"B26","doi-asserted-by":"publisher","first-page":"1031","DOI":"10.1016\/j.neuron.2012.05.009","article-title":"Sustained therapeutic reversal of Huntington\u2019s disease by transient repression of huntingtin synthesis.","volume":"74","author":"Kordasiewicz","year":"2012","journal-title":"Neuron"},{"key":"B27","doi-asserted-by":"publisher","first-page":"E4530","DOI":"10.1073\/pnas.1318835110","article-title":"Targeted degradation of sense and antisense C9orf72 RNA foci as therapy for ALS and frontotemporal degeneration.","volume":"110","author":"Lagier-Tourenne","year":"2013","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"key":"B28","doi-asserted-by":"publisher","first-page":"670","DOI":"10.1016\/S1525-0016(03)00068-6","article-title":"Hammerhead ribozyme-mediated destruction of nuclear foci in myotonic dystrophy myoblasts.","volume":"7","author":"Langlois","year":"2003","journal-title":"Mol. Ther."},{"issue":"490","key":"B29","doi-asserted-by":"publisher","DOI":"10.1186\/1756-0500-4-490","article-title":"Myoblasts generated by lentiviral mediated MyoD transduction of myotonic dystrophy type 1 (DM1) fibroblasts can be used for assays of therapeutic molecules.","volume":"4","author":"Larsen","year":"2011","journal-title":"BMC Res. Notes"},{"key":"B30","doi-asserted-by":"publisher","first-page":"4221","DOI":"10.1073\/pnas.1117019109","article-title":"RNase H-mediated degradation of toxic RNA in myotonic dystrophy type 1.","volume":"109","author":"Lee","year":"2012","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"key":"B31","doi-asserted-by":"publisher","first-page":"2927","DOI":"10.1093\/nar\/gkv143","article-title":"Identification and characterization of intracellular proteins that bind oligonucleotides with phosphorothioate linkages.","volume":"43","author":"Liang","year":"2015","journal-title":"Nucleic Acids Res."},{"key":"B32","doi-asserted-by":"publisher","first-page":"8788","DOI":"10.1093\/nar\/gkt594","article-title":"RNA duplexes with abasic substitutions are potent and allele-selective inhibitors of huntingtin and ataxin-3 expression.","volume":"41","author":"Liu","year":"2013","journal-title":"Nucleic Acids Res."},{"key":"B33","doi-asserted-by":"publisher","first-page":"779","DOI":"10.1111\/bpa.12427","article-title":"RNA toxicity induced by expanded CAG repeats in Huntington\u2019s disease.","volume":"26","author":"Mart\u00ed","year":"2016","journal-title":"Brain Pathol."},{"key":"B34","doi-asserted-by":"publisher","first-page":"13915","DOI":"10.1073\/pnas.0905780106","article-title":"Triplet-repeat oligonucleotide-mediated reversal of RNA toxicity in myotonic dystrophy.","volume":"106","author":"Mulders","year":"2009","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"key":"B35","doi-asserted-by":"publisher","first-page":"8938","DOI":"10.1093\/nar\/gkr608","article-title":"CAG repeats mimic CUG repeats in the misregulation of alternative splicing.","volume":"39","author":"Mykowska","year":"2011","journal-title":"Nucleic Acids Res."},{"key":"B36","doi-asserted-by":"publisher","first-page":"2455","DOI":"10.1002\/cmdc.201402095","article-title":"Small molecules that target the toxic RNA in myotonic dystrophy type 2.","volume":"9","author":"Nguyen","year":"2014","journal-title":"ChemMedChem"},{"key":"B37","doi-asserted-by":"publisher","first-page":"9634","DOI":"10.1093\/nar\/gkt725","article-title":"Rational design of antisense oligonucleotides targeting single nucleotide polymorphisms for potent and allele selective suppression of mutant Huntingtin in the CNS.","volume":"41","author":"Ostergaard","year":"2013","journal-title":"Nucleic Acids Res."},{"key":"B38","doi-asserted-by":"publisher","first-page":"1703","DOI":"10.1242\/jcs.073270","article-title":"Stochastic and reversible aggregation of mRNA with expanded CUG-triplet repeats.","volume":"124","author":"Querido","year":"2011","journal-title":"J. Cell Sci."},{"key":"B39","doi-asserted-by":"publisher","first-page":"133","DOI":"10.1038\/nsmb886","article-title":"Specific and potent RNAi in the nucleus of human cells.","volume":"12","author":"Robb","year":"2005","journal-title":"Nat. Struct. Mol. Biol."},{"key":"B40","doi-asserted-by":"publisher","first-page":"4319","DOI":"10.1172\/JCI83185","article-title":"Targeting CAG repeat RNAs reduces Huntington\u2019s disease phenotype independently of huntingtin levels.","volume":"126","author":"Ru\u00e9","year":"2016","journal-title":"J. Clin. Invest."},{"key":"B41","doi-asserted-by":"publisher","first-page":"10956","DOI":"10.1002\/anie.201406465","article-title":"A toxic RNA catalyzes the in cellulo synthesis of its own inhibitor.","volume":"53","author":"Rzuczek","year":"2014","journal-title":"Angew. Chem. Int. Ed. Engl."},{"issue":"208ra149","key":"B42","doi-asserted-by":"publisher","DOI":"10.1126\/scitranslmed.3007529","article-title":"Targeting RNA foci in iPSC-derived motor neurons from ALS patients with a C9ORF72 repeat expansion.","volume":"5","author":"Sareen","year":"2013","journal-title":"Sci. Transl. Med."},{"key":"B43","doi-asserted-by":"publisher","first-page":"2366","DOI":"10.1073\/pnas.1221891110","article-title":"Aberrant splicing of HTT generates the pathogenic exon 1 protein in Huntington disease.","volume":"110","author":"Sathasivam","year":"2013","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"key":"B44","doi-asserted-by":"publisher","first-page":"157","DOI":"10.1016\/j.phrs.2015.08.002","article-title":"Transcriptional dysregulation in Huntington\u2019s disease: the role of histone deacetylases.","volume":"100","author":"Sharma","year":"2015","journal-title":"Pharmacol. Res."},{"key":"B45","doi-asserted-by":"publisher","first-page":"380","DOI":"10.1038\/mt.2012.222","article-title":"RNA interference targeting CUG repeats in a mouse model of myotonic dystrophy.","volume":"21","author":"Sobczak","year":"2013","journal-title":"Mol. Ther."},{"issue":"1240622","key":"B46","doi-asserted-by":"publisher","DOI":"10.1126\/science.1240622","article-title":"Interneurons from embryonic development to cell-based therapy.","volume":"344","author":"Southwell","year":"2014","journal-title":"Science"},{"key":"B47","doi-asserted-by":"publisher","first-page":"1219","DOI":"10.1038\/nmeth.2701","article-title":"A superfolding Spinach2 reveals the dynamic nature of trinucleotide repeat-containing RNA.","volume":"10","author":"Strack","year":"2013","journal-title":"Nat. Methods"},{"key":"B48","doi-asserted-by":"publisher","first-page":"1043","DOI":"10.1016\/j.neuron.2014.07.041","article-title":"Discovery of a biomarker and lead small molecules to target r(GGGGCC)-associated defects in c9FTD\/ALS.","volume":"83","author":"Su","year":"2014","journal-title":"Neuron"},{"key":"B49","doi-asserted-by":"publisher","first-page":"1513","DOI":"10.1016\/j.bbadis.2016.05.015","article-title":"Nuclear speckles are detention centers for transcripts containing expanded CAG repeats.","volume":"1862","author":"Urbanek","year":"2016","journal-title":"Biochim. Biophys. Acta"},{"key":"B50","doi-asserted-by":"publisher","first-page":"115","DOI":"10.1016\/j.ymeth.2015.11.017","article-title":"RNA FISH for detecting expanded repeats in human diseases.","volume":"98","author":"Urbanek","year":"2016","journal-title":"Methods"},{"key":"B51","doi-asserted-by":"publisher","first-page":"241","DOI":"10.1016\/j.neures.2005.06.021","article-title":"Clinico-pathological rescue of a model mouse of Huntington\u2019s disease by siRNA.","volume":"53","author":"Wang","year":"2005","journal-title":"Neurosci. Res."},{"key":"B52","doi-asserted-by":"publisher","first-page":"18551","DOI":"10.1073\/pnas.0903234106","article-title":"Pentamidine reverses the splicing defects associated with myotonic dystrophy.","volume":"106","author":"Warf","year":"2009","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"key":"B53","doi-asserted-by":"publisher","first-page":"111","DOI":"10.1038\/nature11362","article-title":"Targeting nuclear RNA for in vivo correction of myotonic dystrophy.","volume":"488","author":"Wheeler","year":"2012","journal-title":"Nature"},{"key":"B54","doi-asserted-by":"publisher","first-page":"336","DOI":"10.1126\/science.1173110","article-title":"Reversal of RNA dominance by displacement of protein sequestered on triplet repeat RNA.","volume":"325","author":"Wheeler","year":"2009","journal-title":"Science"},{"key":"B55","doi-asserted-by":"publisher","first-page":"3811","DOI":"10.1093\/hmg\/ddr299","article-title":"Cellular toxicity of expanded RNA repeats: focus on RNA foci.","volume":"20","author":"Wojciechowska","year":"2011","journal-title":"Hum. Mol. Genet."},{"key":"B56","doi-asserted-by":"publisher","first-page":"1","DOI":"10.4161\/rna.28799","article-title":"Small molecule kinase inhibitors alleviate different molecular features of myotonic dystrophy type 1.","volume":"11","author":"Wojciechowska","year":"2014","journal-title":"RNA Biol."},{"key":"B57","doi-asserted-by":"publisher","first-page":"3318","DOI":"10.1093\/nar\/gkv163","article-title":"Short antisense-locked nucleic acids (all-LNAs) correct alternative splicing abnormalities in myotonic dystrophy.","volume":"43","author":"Wojtkowiak-Szlachcic","year":"2015","journal-title":"Nucleic Acids Res."},{"key":"B58","doi-asserted-by":"publisher","first-page":"6355","DOI":"10.1021\/ja5012146","article-title":"Targeting toxic RNAs that cause myotonic dystrophy type 1 (DM1) with a bisamidinium inhibitor.","volume":"136","author":"Wong","year":"2014","journal-title":"J. Am. Chem. Soc."},{"key":"B59","doi-asserted-by":"publisher","first-page":"895","DOI":"10.1016\/j.cell.2012.08.002","article-title":"Single-stranded RNAs use RNAi to potently and allele-selectively inhibit mutant huntingtin expression.","volume":"150","author":"Yu","year":"2012","journal-title":"Cell"}],"container-title":["Frontiers in Cellular Neuroscience"],"original-title":[],"link":[{"URL":"http:\/\/journal.frontiersin.org\/article\/10.3389\/fncel.2017.00082\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2017,3,27]],"date-time":"2017-03-27T23:43:36Z","timestamp":1490658216000},"score":1,"resource":{"primary":{"URL":"http:\/\/journal.frontiersin.org\/article\/10.3389\/fncel.2017.00082\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,3,28]]},"references-count":59,"URL":"https:\/\/doi.org\/10.3389\/fncel.2017.00082","relation":{},"ISSN":["1662-5102"],"issn-type":[{"type":"electronic","value":"1662-5102"}],"subject":[],"published":{"date-parts":[[2017,3,28]]}}}